After treatment with metformin, GLUT4 levels in PCOS patients returned to the baseline of control levels, indicating that metformin can increase peripheral glucose transport and improve IR by affecting GLUT4 expression in the endometrial cells of PCOS patients. Here, SLC2A4 is linked to polycystic ovary syndrome.